S. Kokubo

发表

Effect of rhBMP-2 with PLGA/gelatin sponge type (PGS) carrier on alveolar ridge augmentation in dogs.

Y. Izumi, I. Ishikawa, A. Kinoshita, 2008, Journal of Oral Rehabilitation.

Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial

Min Seon Kim, J. Lee, B. Cha, 2017, Diabetes & metabolism journal.

Fibrocytes are involved in the pathogenesis of human chronic kidney disease.

S. Kaneko, T. Wada, S. Kitajima, 2010, Human pathology.

Polyarteritis nodosa with perirenal hematoma due to the rupture of a renal artery aneurysm

T. Wada, Akinori Hara, S. Kitajima, 2020, CEN Case Reports.

MCP‐1/CCR2‐dependent loop for fibrogenesis in human peripheral CD14‐positive monocytes

S. Kaneko, K. Matsushima, T. Wada, 2006, Journal of leukocyte biology.

p38 MAPK phosphorylation and NF‐κB activation in human crescentic glomerulonephritis

K. Matsushima, N. Mukaida, T. Wada, 2002 .

p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis.

K. Matsushima, N. Mukaida, T. Wada, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Fas Ligand Has a Greater Impact than TNF-α on Apoptosis and Inflammation in Ischemic Acute Kidney Injury

S. Kaneko, K. Matsushima, N. Mukaida, 2012, Nephron Extra.

Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo‐controlled, double‐blind, multicenter trial

B. Cha, L. Chuang, Chieh-hsiang Lu, 2015, Journal of diabetes investigation.

Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury

S. Kaneko, K. Matsushima, T. Sugaya, 2006, Critical care medicine.

Activation of p38 Mitogen-Activated Protein Kinase Promotes Peritoneal Fibrosis by Regulating Fibrocytes

S. Kaneko, K. Matsushima, T. Wada, 2012, Peritoneal Dialysis International.

Comparison of incadronate and alfacalcidol on increased bone turnover caused by ovariectomy in rats.

Koichiro Takahashi, K. Nozaki, S. Kokubo, 2002, European journal of pharmacology.

Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model.

M. Sasamata, K. Nozaki, K. Miyata, 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model.

Koichiro Takahashi, K. Nozaki, K. Miyata, 2003, Biomaterials.

Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy.

T. Wada, H. Kida, Kiyoki Kitagawa, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Interleukin-11 acts synergistically with bone morphogenetic protein-2 to accelerate bone formation in a rat ectopic model.

K. Miyata, S. Kokubo, S. Kaku, 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Recombinant Human Bone Morphogenetic Protein-2 as an Osteoinductive Biomaterial and a Biodegradable Carrier in a Rabbit Ulnar Defect Model

Koichiro Takahashi, K. Nozaki, K. Miyata, 2008 .

Release of recombinant human bone morphogenetic protein 2 from a newly developed carrier.

T. Uchida, T. Sonobe, K. Nozaki, 2003, International journal of pharmaceutics.

Effect of incadronate on corticosteroid-induced osteopenia in rats.

Koichiro Takahashi, K. Nozaki, K. Miyata, 2004, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Long-term stability of bone tissues induced by an osteoinductive biomaterial, recombinant human bone morphogenetic protein-2 and a biodegradable carrier.

M. Mochizuki, N. Sasaki, Teruo Itô, 2004, Biomaterials.

A new recombinant human bone morphogenetic protein-2 carrier for bone regeneration.

T. Uchida, M. Murai, T. Sonobe, 2001, International journal of pharmaceutics.

Effect of sevelamer hydrochloride on markers of bone turnover in Japanese dialysis patients with low biointact PTH levels.

S. Kaneko, T. Wada, Y. Koshino, 2007, Internal medicine.